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Abstract: In plastic surgery, lipofilling is a frequent procedure. Unsatisfactory vascularization
and impaired cell vitality can lead to unpredictable take rates in the fat graft. The proliferation
and neovascularization inducing properties of adipose tissue-derived stem cells may contribute to
solve this problem. Therefore, the enrichment of fat grafts with stem cells is studied intensively.
However, it is difficult to compare these studies because many factors—often not precisely described—
are influencing the results. Our study summarizes some factors which influence the cell yield
like harvesting, isolation procedure and quantification. Stem cells were isolated after liposuction.
Quantification was done using a cell chamber, colony counting, or flow cytometry with changes to
one parameter, only, for each comparison. Quantification of cells isolated after liposuction at the
same harvesting site from the same patient can vary greatly depending on the details of the isolation
protocol and the method of quantification. Cell yield can be influenced strongly by many factors.
Therefore, a comparison of different studies should be handled with care.
Keywords: plastic surgery; adipose tissue; lipoaspirate; stem cells; fat grafting; cell yield; adipocyte
viability
1. Introduction
Adipose tissue derived stem cells (ASCs) are mesenchymal stem cells (MSCs) with
properties comparable to those of bone marrow stromal cells (BMSCs) [1]. They fulfill all
criteria for MSCs proposed by the Mesenchymal and Tissue Stem Cell Committee of the
International Society for Cellular Therapy [2]. ASCs grow plastic adherent in standard
culture conditions and express surface markers CD44, CD73, and CD90 but not CD45
and HLA-DR. They have the potency to differentiate into osteoblasts, adipocytes and
chondroblasts in vitro [3,4]. Additionally, it has been shown that ASCs can be induced to
differentiate into myogenic, neurogenic, angiogenic, and hepatic lines [5–10]. However,
the main advantage of ASCs over BMSCs is the possibility to harvest regenerative cells in
much larger quantities with minimally invasive procedures [1,11].
The term fat grafting or lipofilling describes a procedure that is commonly applied in
clinical practice to treat volume and contour defects in soft tissues [12]. Indeed, lipofilling
is a common procedure in plastic surgery [13,14]. However, the graft stability follow-
ing autologous fat transplantation remains unpredictable with absorption rates of up to
70% [15–17]. These high absorption rates are believed to be related to both reduced cell via-
bility after liposuction associated stress and to lacking angiogenesis of the transplant [18,19].
Therefore, graft survival is closely related to cell viability after liposuction and subsequent
vascularization of the grafted cells. It has been reported previously that the number and
viability of grafted cells and their potential for neovascularization is important for the
outcome of lipofilling [20–24]. Both problems could be solved by a higher number of ASCs
because of their potential to replenish the cell number and because of their angiogenic
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properties [9,25–27]. Therefore, many studies aim to achieve an ASC-enriched lipoaspirate
either by concentrating the aspirate or by supplementation with isolated ASCs (cell-assisted
lipotransfer) [21,28,29].
Enzymatic digestion of fat tissue with collagenase lead to high ASC yield. Safety
concerns about the manipulation of fat tissue cells and the use of xeno-origin enzymes
necessitate the modification of digestion-free isolation methods for the purpose of routine
patient treatment [30]. Whereas cutting, harvesting, or centrifuging represent only minimal
manipulation of the cells, enzymatic digestion can be considered as a substantial manipu-
lation with changes in cell characteristics and is therefore seen problematic by regulating
authorities. Besides the cell manipulation, residual enzyme activity in the lipograft needs
to be avoided. An abundance of studies has been published on various procedures to
optimize ASC yield without enzymatic digestion, either by concentrating the lipoaspirate
or by isolating the stem cells with mechanical procedures, only. However, in order to
quantify the outcome of these efforts the use of collagenase still remains the standard
method. Despite most authors apply comparable procedures of enzymatic digestion, re-
sults regarding stem cell yield vary greatly among these studies. This became evident
when Locke et al. presented a review of studies that reported stem cell yields from adipose
tissue ranging from 30,000 to 2,000,000 cells per mL lipoaspirate [11,31–34]. A review by
Pak et al. published in 2017 reported a range from 500,000 to 2,000,000 nucleated cells
per mL fat tissue with an ASC percentage ranging from 1% to 10% [35,36], resulting in a
possible total range for ASCs from 5000 to 200,000 cells per mL. Obviously, this wide range
has important implications for the comparison of reported stem cell yields of proposed
novel enzyme-free stem cell enrichment procedures. Different counting method bear the
problem, that different cell populations are compared with each other. Many, but not all
plastic adherent cells from the stromal vascular fraction will be positive for MSC surface
markers or will be colony-forming. Therefore, we utilize “cell yield” rather than “stem cell
yield” when comparing different counting methods.
The objective of the study presented here is to compare the influence of variations of
specific factors on the outcome of the cell yield to further improve lipotransfer procedures.
2. Materials and Methods
2.1. Adipose Tissue Harvest
Lipoaspirate from liposuctions was obtained from subcutaneous adipose tissue upon
patients’ informed consent. Collection of lipoaspirate waste and isolation of cells had been
approved by the Ethics Committee (08/117) of the University Hospital of Regensburg after
patient’s informed consent. Liposuction was performed as described in the S2K guideline.
Briefly, a 0.9% (w/v) solution of sodium chloride containing adrenaline (1:200,000) was
infiltrated using a 2.5-mm injection cannula (Human Med AG, Schwerin, Germany) [37].
Liposuction was performed water jet–assisted with an even negative pressure of less than
0.5 mbar (Body-Jet, Human Med AG) using 3.8-mm cannulas (Human Med AG).
2.2. Lipoaspirate Handling
Lipoaspirate was either used directly after liposuction (control) or centrifuged for
5 min at 300 rcf. Blood and tumescence fluid were discarded and the lipoaspirate super-
natant was further processed.
2.3. Stem Cell Isolation
ASC isolation was carried out as previously described [38]. Briefly, for enzymatic
digestion the adipose tissue was mixed with an equal volume of alpha MEM (Sigma Alrich,
St. Louis, MO, USA) and 10 µL per mL of a 100 U/mL collagenase (Collagenase from
Clostridium histolyticum Sigma Blend Type L (Clostridiopeptidase A) in PBS solution (both
Sigma Aldrich) and incubated for 45 min at 37 ◦C at constant shaking. Subsequently, the
digested tissue is forced through a 100-µm filter (Merck-Millipore, Billerica, MA, USA)
and centrifuged at 500 rcf for 5 min. The entire suspension except for the cell pellet
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containing the stromal vascular fraction (SVF) was discarded. In some cases, the cells
were incubated with an erythrocyte lysis buffer (see below). Resuspended cells were either
analyzed by flow cytometry (see below) or seeded into 6-well plates in cell culture medium
(α-MEM (Sigma-Aldrich)) containing 20% heat-inactivated FBS (Pan-Biotech, Aidenbach,
Germany), 2 mM glutamine (Thermo Fisher, Waltham, MA, USA), 100 U/mL penicillin,
and 100 µg/mL streptomycin (both Sigma-Aldrich).
2.4. Erythrocyte Lysis
For erythrocyte lysis the cell pellet was resuspended in erythrocyte lysis buffer con-
taining 155 mM NH4Cl, 10 mM KHCO3, and 0.1 mM EDTA in PBS (all Sigma Aldrich)
and incubated for 6 min. Subsequently cells were centrifuged, and the supernatant was
discarded. After a washing step with PBS, the cells were handled as the cells that had not
been treated with lysis buffer.
2.5. Flow Cytometry
Flow cytometry was done as previously described [39]. Briefly, cells were washed
with FACS-buffer (containing 0.01% sodium azide, 0.5% BSA, and 2 nM EDTA, all Sigma
Aldrich) three times. For antibody incubation, cells were resuspended in 40 µL FACS-buffer
supplemented with either 5 µL APC anti-human CD90 Antibody and 5 µL Alexa Fluor®
488 anti-mouse/human CD44 antibody or their respective isotype controls (APC Mouse
IgG1, κ Isotype Ctrl (FC) Antibody, Alexa Fluor® 488 Rat IgG2b, κ Isotype Ctrl Antibody,
all BioLegend, San Diego, CA, USA). After incubation on ice in the dark for 1 h, 1 mL
FACS-buffer was added and the cells were centrifuged. The supernatant was discarded,
and cells were resuspended in 500 µL FACS-buffer and measured using the FACS Canto
II (BD Biosciences, Heildelberg, Germany). At least 50,000 events of each sample were
recorded. Figures were created using FlowJo Version 10.7.1 (FlowJo LLC, Becton, Dickinson
& Company, Franklin Lakes, NJ, USA).
2.6. Cell Counting
Cells seeded in 6-well plates were used for cell counting. Seeded cells were allowed to
adhere for 24 h and afterwards washed thoroughly with PBS, disposing all non-adherent
cells. Cell counting was done using two different methods. For the first method the cell
equivalent of 1 mL lipoaspirate was seeded. After 24 h when the cells were given time to
adhere but not to proliferate cells were washed thoroughly, fixed with 10% formalin, and
stained with a 0.02% (w/v) crystal violet solution. Pictures from random sites of the plate
surface were taken with the Wilovert S microscope (Helmut Hund GmbH, Wetzlar) and
the ScopeTec DCM 800 camera, using the Scope Photo 3.0 software. The number of cells
per cm2 was counted and projected to the complete well area. For the second method, a
colony forming unit assay, the cell equivalent of 10 µL lipoaspirate was seeded to assure
that single colonies can be observed. After adherence and washing, the cells were cultured
for 14 days. Afterwards, cells were fixed with 10% formalin and stained with a 0.02% (w/v)
crystal violet solution. The number of macroscopically visible colonies were counted and
projected to the equivalent of 1 mL lipoaspirate which was used for adherence counting
method. Results are shown as mean of five wells ± SD. To facilitate the direct comparison
of parameter impact, results are shown as normalized values.
A schematic representation of the experimental process is shown in Figure 1.
2.7. Statistical Analysis
Student’s t-test was used for statistical analysis. P-values below 0.05 were considered
statistically significant.




Figure 1. Schematic presentation of the experiment process. After liposuction the lipoaspirate is ei-
ther allowed to sediment or centrifuged. An aliquot is taken from both samples and used for analysis 
of the parameter centrifugation. The rest of the sedimented lipoaspirate underwent the Adipose 
tissue-derived stem cell isolation protocol either with or without erythrocyte lysis buffer. An aliquot 
is taken from both samples and used for analysis of the parameter erythrocyte lysis. The rest of the 
cells isolated without lysis buffer are seeded in two different seeding concentrations and were ana-
lyzed for this parameter. The rest of the cells isolated with erythrocyte lysis buffer, which is a pre-
requisite for flow cytometry anyway, underwent either FACS analysis or were seeded as described 
above. 
2.7. Statistical Analysis 
Student’s t-test was used for statistical analysis. P-values below 0.05 were considered 
statistically significant. 
3. Results 
3.1. Lipoaspirate Handling 
Isolated cells from lipoaspirate that was either centrifuged directly after liposuction 
or unprocessed were seeded into 6-well plates and allowed to adhere. After 24 h the cells 
were washed thoroughly, fixed, stained, and counted under an inverse microscope. After 
lipoaspirate was separated from tumescence solution and free lipids by centrifugation, 
stem cell yield per milliliter lipoaspirate is increased 1.3-fold per mL (Figure 2). 
3.2. Erythrocyte Lysis 
Quantification was performed as described for the lipoaspirate centrifugation com-
parison. Directly after stem cell isolation and prior to seeding cells were incubated with 
an erythrocyte lysis buffer. Cell yield after treatment with isolation buffer was increased 
more than 2.5-fold (Figure 3). 
3.3. Colony Forming Unit Assay 
After the isolation the cell equivalent of either 1 mL or 10 µL lipoaspirate was seeded 
into 6-well plates. Adherent cells from the 1 mL equivalent were counted after 24 h, 
formed colonies from the 10 µL equivalent were counted after two weeks and multiplied 
by 100 (Figure 4). 
Figure 1. Schematic presentation of the experim nt process. After liposuction the lipoaspirate is either allowed to s diment
or c ntrifuged. An aliquot is aken from both samples and used for analysis of e param ter centrifugation. The re t
of the s dimented lipoaspirate nderwent t Adipose tissue-deriv d stem cell isolation protocol either with or without
erythrocyte lysis buffer. An aliquot is taken from both samples and used for analysis of the parameter erythrocyte lysis. The
rest of the cells isolated without lysis buffer are seeded in two different seeding concentrations and were analyzed for this
parameter. The rest of the cells isolated with erythrocyte lysis buffer, which is a prerequisite for flow cytometry anyway,
underwent either FACS analysis or were seeded as described above.
3. Results
3.1. Lipoaspirate Handling
Isolated cells from lipoaspirate that was either centrifuged directly after liposuction
or unprocessed were seeded into 6-well plates and allowed to adhere. After 24 h the cells
were washed thoroughly, fixed, stained, and counted under an inverse microscope. After
lipoaspirate was separated from tumescence solution and free lipids by centrifugation,
stem cell yield per milliliter lipoaspirate is increased 1.3-fold per mL (Figure 2).
3.2. Erythrocyte Lysis
Quantification was performed as described for the lipoaspirate centrifugation compar-
ison. Directly after stem cell isolation and prior to seeding cells were incubated with an
erythrocyte lysis buffer. Cell yield afte tr atment with isolation buff was increased more
than 2.5-fold (Figure 3).
3.3. Colony Forming Unit Assay
After the isolation the cell equivalent of either 1 mL or 10 µL lipoaspirate was seeded
into 6-well plates. Adherent cells from the 1 mL equivalent were counted after 24 h,
formed colonies from the 10 µL equivalent were counted after two weeks and multiplied
by 100 (Figure 4).
3.4. Flow Cyto etry Analysis
After the isolation process cells were either seeded into 6-well plates or underwent
flow cytometry analysis. An aliquot of the cells for flow cytometry was used to c lculate the
total number of cells with a Neubauer chamber. Using the percentage of the CD44+CD90+-
positive cells the number of ASCs was quantified. The quantification of the adherent cell
counting method showed 15 times more cells than the ASCs detected by flow cytometry
quantification (Figure 5). Only a small percentage of the cells resuspended from the SVF is
positive for CD44 and CD90 (Figure 6). However, cells that are isolated from adipose tissue
and cultured for several days on well plate surfaces with α-MEM are highly positive for
CD44 or CD90 (Figure 7).




Figure 2. (A) Cell yield is increased 1.3-fold per mL when lipoaspirate is centrifuged directly after liposuction. For this 
comparison, the counting of adherent cells after 24 h was used. Results are shown as mean ± SD. Student’s t-test was used 
to assess statistical significance (*: p < 0.05). (B) Representative image of cells isolated from sedimented lipoaspirate. (C) 
Representative image of cells isolated from centrifuged lipoaspirate. The bar measures 100 µm. 
Figure 2. (A) Cell yield is increased 1.3-fold per mL n lipoaspirate is centrifuged directly after liposuction. For th s
comparison, the counting of adherent cells after 24 h was used. Results are shown as mean ± SD. Student’s t-test was
used to assess statistical significance (*: p < 0.05). (B) Representative image of cells isolated from sedimented lipoaspirate.
(C) Representative image of cells isolated from centrifuged lipoaspirate. The bar measures 100 µm.




Figure 3. (A) Cell yield is increased more than 2.5-fold per mL when cells are incubated with an erythrocyte lysis buffer 
after stem cell isolation and prior to seeding. For this comparison, the counting of adherent cells after 24 h was used. 
Results are shown as mean ± SD. Student’s t-test was used to assess statistical significance (***: p < 0.001). (B) Representative 
image of seeded cells directly after seeding without red blood cell lysis buffer. The whole surface is covered with erythro-
cytes. (C) Representative image of seeded cells directly after seeding with red blood cell lysis buffer. Although many 
erythrocytes remain in the suspension, there is free surface area for the adipose tissue cells to adhere. The bars measure 
100 µm. 
Figure 3. (A) Cell yield is increased more than 2.5-fold per mL when cells are incubated with an erythrocyte lysis buffer
after stem cell isolation and prior to seeding. For this comparison, the counting of adherent cells after 24 h was used. Results
are shown as mean ± SD. Student’s t-test was used to assess statistical significance (***: p < 0.001). (B) Representative image
of seeded cells directly after seeding without red blood cell lysis buffer. The whole surface is covered with erythrocytes.
(C) Representative image of seeded cells directly after seeding with red blood cell lysis buffer. Although many erythrocytes
remain in the suspension, there is free surface area for the adipose tissue cells to adhere. The bars measure 100 µm.




Figure 4. (A) Calculated cell yield is roughly 10 times higher when the adherent cell counting 
method is used compared to the colony forming unit assay. Results are shown as mean of five 
wells ± SD. Student’s test was used to assess statistical significance (***: p < 0.001). (B) A single 
colony after a few days of culture. The bar measures 100 µm. (C) The stained (crystal violet) colo-
nies can be seen macroscopically after two weeks. 
3.4. Flow Cytometry Analysis 
After the isolation process cells were either seeded into 6-well plates or underwent 
flow cytometry analysis. An aliquot of the cells for flow cytometry was used to calculate 
the total number of cells with a Neubauer chamber. Using the percentage of the 
CD44+CD90+-positive cells the number of ASCs was quantified. The quantification of the 
adherent cell counting method showed 15 times more cells than the ASCs detected by 
flow cytometry quantification (Figure 5). Only a small percentage of the cells resuspended 
from the SVF is positive for CD44 and CD90 (Figure 6). However, cells that are isolated 
from adipose tissue and cultured for several days on well plate surfaces with α-MEM are 
highly positive for CD44 or CD90 (Figure 7). 
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Figure 5. Calculated cell yield from the same lipoaspirate is decreased about 15-fold when detecting 
the CD44+CD90+-positive ASCs with flow cytometry instead of counting the adherent cells after 24 
h. Results are shown as mean ± SD. Student’s test was used to assess statistical significance (***: p < 
0.001). 
Figure 5. Calculated cell yield from the same lipoaspirate is decreased about 15-fold when detecting the CD44+CD90+-
positive ASCs with flow cytometry instead of counting the adherent cells after 24 h. Results are shown as mean ± SD.
Student’s test was used to assess statistical significance (***: p < 0.001).
4. Discussion
High absorption rates are still considered the main concern in autologous fat transplan-
tation [40]. Evidently, ASCs contribute to fat graft survival not only by their proliferative
capacities but also by paracrine angiogenic properties [9,41]. Therefore, enrichment of
lipoaspirate with ASCs is intensively investigated by numerous groups [36,42–46]. Safety
concerns regarding enzymatic digestion of fat tissue have led to an increasing recognition
of methods that circumvent the risks of enzymatic digestion [29]. Both the concern of
substantial changes in cellular properties and residual collagenase activity have shifted the
focus to enzyme-free stem cell enrichment processes for the clinical application. However,
irrespective of the applied method enzymatic digestion remains the gold standard for the
in vitro quantification of stem cells yields. An exceeding number of studies focus on stem
cell isolation from adipose tissue. However, the results for stem cell yield vary greatly
among studies, even without efforts to optimize stem cell content [34,36]. The objective of
this study is to summarize parameters that influence the reported cell yield from fat tissue
grafts and to evaluate the cell yield after varying single parameters during the isolation or
quantification procedure.
It is believed that the number of ASCs can be influenced by donor demographics like
age, gender, and BMI. Most studies report a negative correlation of BMI and ASC content
per volume lipoaspirate [32,47], while other studies did not find significant differences [48].
Whereas most studies found no significant correlation between initial ASC yield and donor
age [32,47,49] one study referring to a highly proliferative ASC subpopulation reported
significant differences in ASC yield from older patients [50]. Other studies suggested
that not ASC yield but ASC quality in terms of proliferation capacity and differentiation
potential is impaired in older patients [51–53]. Similar observations exist for the correlation
of ASCs and gender. The quantification method determines the difference in proliferation
capacity and hence may as well influence graft survival. Apart from that, these findings
have implications that should be considered when using fat tissue grafts for regenerative
purposes. Essentially, neither demographic variables nor parameters may solely explain
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the broad range in stem cell yield found in the literature, but may contribute to this great
variance, especially when cells are allowed to proliferate prior to quantification.




Figure 6. (A) Forward Scatter/Sideward Scatter Plot for cells isolated from adipose tissue. The gated 
cell population is shown. (B) Cells stained with isotype control antibodies are in the lower left quad-
rant of an APC/AlexaFluor488 Plot. For isotype control cytometry 50,000 events were counted (left). 
After staining with specific antibodies for CD44/CD90, nearly 0.5% of cells are positive for 
CD44/CD90. Arrows point to the main population. For specific antibody cytometry 100,000 events 
were counted. One of four measurements is shown. (right). 
Figure 6. (A) Forward Scatter/Sideward Scatter Plot for cells isolated from adipose tissue. The gated cell population is
shown. (B) Cells stained with isotype control antibodies are in the lower left quadrant of an APC/AlexaFluor488 Plot. For
isotype control cytometry 50,000 events were counted (left). After staining with specific antibodies for CD44/CD90, nearly
0.5% of cells are positive for CD44/CD90. Arrows point to the main population. For specific antibody cytometry 100,000
events were counted. One of four measurements is shown. (right).




Figure 7. Cultured ASCs are positive for CD44 and CD90. 
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Whereas it is impossible for the surgeon to influence donor demographics, there
are other outcome-related p rameters during liposuction that may be c ntr lled by the
clinician: amely tissue-harvesting technique and tissue-har esting site. Oeday ajsingh-
V rma et al. did not find statistically significa t differences in cell yield from abdomen,
hip/thigh, and mamma tissue [54]. However, in this study o ly the number of nucleated
cells was evaluated without further distinction. Fraser et al. reported a significantly
higher yield of colony-forming cells from hip-harvested lipoaspirate than from abdomen-
harvested fat tissue [55], whereas Jurgens et al. reported contrary results [56]. It is of
note that the studies from both Oedayrajsingh-Varma et al. and Jurgens et al. compared
different tissue harvesting sites from different patients whereas Fraser et al. harvested
lipoaspirate from different sites of the same patient. Given the fact that donor demographics
may influence the outcome, the comparison of harvesting sites within the same patient
might be more reliable. The third outcome related parameter is the tissue-harvesting
technique itself. When fat tissue resection, tumescent liposuction, and ultrasound assisted
liposuction were assessed regarding post-harvesting cell viability, no statistically significant
differences were found. Nevertheless, the resected tissue showed significantly higher yields
of adherent proliferating cells [54]. Ozsoy et al. evaluated the influence of cannula sizes
during the injection and aspiration process [57]. Injection cannula diameters of 1.5, 2.0,
and 2.5 mm as well as aspiration cannula diameters of 2, 3, and 4 mm were investigated
for this purpose. Whereas the size of injection cannula seemed to be of negligible impact,
the lipoaspirate harvested with 4 mm aspiration cannulas yielded twice as many viable
cells as the lipoaspirate harvested with the 2 mm aspiration cannula. Another study
compared the conventional fat-harvesting technique as described by Coleman [58] to a
novel micro-fat-harvesting technique. Although, no significant differences in initial cell
yields were observed, cells harvested with the micro-fat technique showed significantly
higher adherence. Again, depending on the quantification method, this can account for
huge differences in the outcome.
The study presented here compared the influence of four distinct parameters on
the cell yield: the lipoaspirate handling immediately after liposuction (centrifugation
vs. sedimentation), specific details of the isolation protocol (erythrocyte lysis), as well
as the quantification method (adherent cells vs. CFUs, microscopy vs. flow cytometry).
Although the investigated cells were of the exact same adipose tissue origin, all of the
4 mentioned parameters variably contributed to differences in the observed cell yield.
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Firstly, centrifugation of the lipoaspirate lead to a 1.3-fold increase in adherent cell yield.
Although this could be expected of more concentrated lipoaspirate, it illustrates that the
comparison of total numbers from different studies is difficult. This phenomenon may as
well confound results when lipoaspirate is allowed to sediment by gravity for different time
spans. Regardless, precise information on centrifugation and duration of sedimentation is
yet rarely considered in “Material and Methods” of published experiments.
The incubation with erythrocyte lysis buffer had a high impact on adherent cell
yield. In fact, more than 2.5-fold more cells were detected with the adherent cell counting
quantification when cells underwent erythrocyte lysis treatment prior to seeding. This
might be explained by the fact that the vast majority of cells contained in lipoaspirate
are erythrocytes and that these cells simply competitively interfere with attachment to
the surface. Figure 3B,C illustrate that the free culture plate surface differs greatly with
and without erythrocyte lysis. It is of note that studies that claim stem cell yields at
the upper end of the broad range integrate a red blood cell lysis step into their isolation
protocol [11,59]. In contrast, studies which report a stem cell yield at the lower end of that
range tend to skip that step [31,32,60]. However, opposing examples can be found, and all
these studies are distinguished by more than this parameter, rendering this comparison
unreliable. Furthermore, it is important to notice that this might be just an artifact caused
by the vast abundance of erythrocytes impairing the culture surface adherence of the
adipose cells without any significance in a purely clinical setting. However, in this case
it is also important to realize that differences in the observed laboratory cell yield caused
by the utilization or the omission of erythrocyte lysis buffer would have no implication
for lipografting.
The quantification method showed the biggest effect on the observed cell yield. Both
the comparison of adherent cell counting method with colony forming unit assay method
and the comparison of adherent cell counting method with flow cytometry analysis resulted
in large difference in the observed cell yield.
The calculated cell yield is roughly 10 times lower when the number of colonies is
the basis for the cell yield calculation. This is based on the fact that the capability of cells
to adhere to the surface does not necessarily imply the capability to form colonies. Only
a part of the cells of the SVF adhere to the cell culture surface, and of those, only a part
can form colonies. This is in accordance with the reported frequency of stem cells in the
stromal vascular fraction between 0.1% and 5% [57,61,62].
Measuring the stem cell yield by evaluating the percentage of CD44+CD90+-positive
cells leads to a result that is 15 times lower than that reached with the adherent cell counting
method. This cannot be explained with the fact that only a small percentage of the adherent
cells express these surface markers. Flow cytometry with cells that were cultured for a few
days after isolation are nearly 100% positive for these markers (Figure 7). One can only
speculate about the reasons. The obvious explanation is that far more cells from the SVF
are culture surface adherent than the CD44+CD90+ ASCs.
It is important to notice that the different cell yields observed after different quantifica-
tion methods are in fact caused by the examination of different cell populations. However,
this only emphasizes the conclusion that reported cell yields from different studies are
difficult to compare.
5. Conclusions
There is consensus that there is a great clinical need to optimize stem cell yields with
non-enzymatic methods during lipotransfer. However, donor demographics, harvesting
site, harvesting method, lipoaspirate handling, isolation method, as well as the quantifica-
tion procedure itself all have a strong impact on the observed cell enrichment. This should
be taken into account when comparing different studies. Meta-analyses especially should
be interpreted with care.
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